TITLE

FDA Actions

PUB. DATE
December 2011
SOURCE
Travel Medicine Advisor;Dec2011 Supplement, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers news briefs related to the U.S. Food and Drug Administration (FDA). A review which aims to examine the association of oral contraceptives and thrombotic risk has been issued by the FDA. Olanzapine (Zyprexia) has been approved by the FDA for the treatment of schizophrenia and bipolar disorder. The FDA has announced the withdrawal of drotrecogin alfa (Xigris), a drug manufactured by Eli Lilly & Co., from the market.
ACCESSION #
67762813

 

Related Articles

  • FDA Actions.  // Neurology Alert;Dec2011 Pharmacology Watch, p2 

    The article presents updates on the actions by the U.S. Food and Drug Administration (FDA) as of December 2011. The FDA is reviewing the association of oral contraceptives and thrombotic risk, particularly oral contraceptives containing drospirenone. The first generic olanzapine (Zyprexa) to...

  • FDA Actions.  // Infectious Disease Alert;Dec2011 Pharmacology Watch, p2 

    The article presents updates on actions taken by the U.S. Food and Drug Administration (FDA) as of December 2011. A review is being conducted by the FDA on the link between oral contraceptives and thrombotic risk. Approval was granted by the FDA to the first generic olanzapine indicated for...

  • Antipsychotic cleared for bipolar disorder.  // Drug Topics;1/26/2004, Vol. 148 Issue 2, p8 

    Reports on the approval of olanzapine from Eli Lilly and Co. for the maintenance treatment of bipolar disorder by the U.S. Food and Drug Administration.

  • FDA APPROVES LILLY'S ZYPREXA RELPREVV FOR TREATMENT OF SCHIZOPHRENIA IN ADULTS.  // Psychiatry (1550-5952);Dec2009, Vol. 6 Issue 12, p9 

    The article reports on the U.S. Food and Drug Administration's (FDA) approval of the extended-release injectable suspension drug Zyprexa Relprevv from Eli Lilly & Co. for the treatment of schizophrenia in adult patients. It notes that Zyprexa Relprevv is a long acting formulation that can last...

  • FDA Actions. Elliott, William T. // Neurology Alert;Dec2011, Vol. 30 Issue 4, p2 

    The article offers updates related to the U.S. Food and Drug Administration. The FDA is reviewing the association of oral contraceptives with drospirenone and thrombotic risk. The agency has approved the first generic olanzapine for schizophrenia and bipolar disorder therapy. It has announced...

  • FDA signs off on manufacturing operations. Maurer, Katie // Indianapolis Business Journal;11/10/2003, Vol. 24 Issue 35, p37 

    Reports that the U.S. Food and Drug Administration has cleared Eli Lilly and Co. of manufacturing problems at two Indianapolis plants in Indiana. Approval of drugs; Availability of drugs.

  • ELI LILLY. Investor's Business Daily // Investors Business Daily;4/22/2014, pA02 

    The article reports on the U.S. Food and Drug Administration's (FDA) approval of the ramucirumab advanced stomach cancer drug from pharmaceutical firm Eli Lilly & Co.

  • Advances in Diabetes Medications Continue.  // Chain Drug Review;3/16/2015, Vol. 37 Issue 5, p82 

    The article reports that the U.S. Food and Drug Administration (FDA) has approved the launch of the Glyxambi drug for type 2 diabetes patients from Eli Lilly and Co. and Boehringer Ingelheim Pharmaceuticals Inc.

  • Lilly gets a string of small victories.  // Indianapolis Business Journal;11/22/2010, Vol. 31 Issue 38, p13A 

    The article reports on the drug approval of Eli Lilly and Co.'s antidepressant Cymbalta to treat chronic pain by the Food and Drug Administration's (FDA) in the U.S.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics